Most patients do not need to be convinced that physical activity is good for them. They have heard the message from clinicians, public health campaigns, family members, television commercials and …
Category:
Health
-
-
The dominant story about antimicrobial resistance is a story about scarcity. We are told there are not enough new antibiotics, that the pipeline is broken, that the economics of antibiotic …
-
Allswell, a behavioral health company for the LGBTQ+ community, announced on Wednesday that it raised $7 million in seed funding. The company provides one-on-one virtual therapy, group programs and trauma-informed …
-
OMass Therapeutics now has $310 million in financing to support a pipeline led by a drug in development for a rare endocrine disorder with limited treatment options. The disease is …
-
Robotics are increasingly being incorporated into today’s complex surgeries, and their capabilities are quickly expanding as they take on new tasks and higher levels of autonomy. The FDA recently published …
-
Health
Join Us at INVEST Digital Health for a Conversation on Consumer-Centered Care across the Healthcare Ecosystem
The annual INVEST Digital Health conference is coming up! Scheduled for October 29 in Dallas at Pegasus Park, in collaboration with Health Wildcatters, consumer influence in healthcare is the theme …
-
MedTech manufacturers are navigating greater regulatory complexity, shrinking margins, and growing expectations for highly specialized products. They’re also under pressure to generate revenue beyond the initial sale via service contracts, …
-
For decades, American health systems have operated on an increasingly precarious regime of financial tradeoffs: commercially insured surgical patients cross-subsidize Medicare, Medicaid, and uninsured patients. Hospital outpatient fees underwrite employed …
-
Currently, more than 40% of American adults don’t take their medications as prescribed due to cost concerns. That’s why healthcare software company Epic is introducing a new offering called Prescription …
-
Using RNA to interfere with a disease-driving protein is a proven way to address disease targets in the liver. City Therapeutics is one of the companies developing the next-generation of …